The Food and Drug Administration held its first public hearing on May 31, 2019 concerning products containing cannabis or cannabis-derived compounds (in particular, cannabidiol (CBD), a popular additive to food, beverages and supplements). This new focus reflects the burgeoning popularity of CBD as an additive to consumables, driven by the compound’s much-touted health benefits.

Although FDA Deems CBD ‘Unsafe,’ There Has Been No FDA Enforcement

The FDA currently classifies all products containing CBD (including those derived from hemp, in accordance with the 2018 Farm Bill) as “unsafe” under the Federal Food, Drug, and Cosmetic Act (FDCA). Despite this designation, the agency’s general approach to CBD enforcement suggests that it does not believe the substance should face outright prohibition and that CBD has gained widespread acceptance.

Click here to read the full article.